|
US2019295683A1
|
|
Systems and methods for non-hormonal female contraceptive drug target identification and prioritization
|
|
US2019277856A1
|
|
Methods for assessing risk of increased time-to-first-conception
|
|
EP3614914A1
|
|
A measurement system and method for defining and determining an ovarian reserve
|
|
WO2018187585A1
|
|
Methods for assessing the potential for reproductive success and informing treatment therefrom
|
|
WO2018175435A2
|
|
System and method for processing electronic medical and genetic/genomic information using machine learning and other advanced analytics techniques
|
|
EP3582799A1
|
|
Methods for assessing the probability of achieving ongoing pregnancy and informing treatment therefrom
|
|
US2018108431A1
|
|
Methods and systems for assessing fertility based on subclinical genetic factors
|
|
US2017351806A1
|
|
Method for assessing fertility based on male and female genetic and phenotypic data
|
|
SG11201807694WA
|
|
Methods and systems for assessing infertility and ovulatory function disorders
|
|
US2017107573A1
|
|
Methods and systems for assessing infertility as a result of declining ovarian reserve and function
|
|
WO2017015023A2
|
|
Methods and systems for endometrial treatment
|
|
SG11201700303UA
|
|
Methods and systems for assessing infertility and related pathologies
|
|
US2015142331A1
|
|
Methods and devices for assessing risk of female infertility
|
|
AU2015209126A1
|
|
Methods for assessing whether a genetic region is associated with infertility
|
|
US2014171337A1
|
|
Methods and devices for assessing risk of female infertility
|
|
US2014107934A1
|
|
Systems and methods for determining the probability of a pregnancy at a selected point in time
|
|
AU2013331696A1
|
|
Systems and methods for determining the probability of a pregnancy at a selected point in time
|
|
CA2850930A1
|
|
Methods and devices for assessing risk to a putative offspring of developing a condition
|
|
AU2010351560A1
|
|
Methods and devices for assessing infertility and/or egg quality
|
